Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activating signal cointegrator 1 complex subunit 1 (ASCC1) is a nuclear protein encoded by the ASCC1 gene. It is a subunit of the ASC-1 transcriptional coactivator complex, which interacts with transcription factors and nuclear receptors to regulate tissue-specific gene transcription. ASCC1 is also part of the DNA damage response ASCC complex, playing a pivotal role in DNA repair mechanisms. It enhances NF-kappa-B, SRF, and AP-1 transactivation and is implicated in the induction of certain genes (e.g., SERPINB2) in response to signaling cues. ASCC1 is highly expressed in the central nervous system and other tissues during development, and its loss-of-function is associated with severe congenital neuromuscular syndromes, including prenatal spinal muscular atrophy and multiple congenital contractures[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activating signal cointegrator 1 complex subunit 1 (ASCC1).